What is ARGX stock price today?

ARGX (argenx NV ADR) stock is trading at $891.32 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ARGX stock going up or down today?

ARGX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ARGX stock now?

The decision to buy ARGX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ARGX a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ARGX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ARGX stock overvalued or undervalued?

ARGX currently trades at a P/E ratio of 37.26, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if ARGX is fairly priced.

What is ARGX's P/E ratio?

ARGX has a price-to-earnings (P/E) ratio of 37.26, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is ARGX's market cap?

ARGX (argenx NV ADR) has a market capitalization of $52.35 billion, making it a mid-cap stock.

What is ARGX's price to book ratio?

Price-to-book ratio for ARGX is available on our dashboard along with other valuation metrics.

Does ARGX pay dividends?

ARGX does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ARGX's dividend yield?

ARGX does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ARGX stock a good long-term investment?

ARGX's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ARGX's revenue growth rate?

Revenue growth data for ARGX is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ARGX are available on our dashboard with complete income statement analysis.

What are the risks of investing in ARGX?

Key risks for ARGX include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ARGX compare to its competitors?

Compare ARGX to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ARGX's performance and positioning.

What is ARGX's stock price target for 2026?

Our AI model provides price targets for ARGX based on fundamental analysis: Bull case $1158.72 (+30%), Base case $1025.02 (+15%), Bear case $802.19 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ARGX?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ARGX. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ARGX's next earnings report?

ARGX reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ARGX - argenx NV ADR

NYSE * Healthcare * Biotechnology

$891.32

+$49.05 (+5.82%)

About argenx NV ADR

argenx NV ADR (ARGX) common stock

Price Chart

Loading chart...

ARGX Key Statistics

Market Cap

$52.35B

P/E Ratio

37.26

How ARGX Compares to Peers

ARGX trades at a premium valuation vs peers (highest P/E)

ARGX is the smallest among peers, which may offer higher growth potential

P/E Rank

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 5

Company	Market Cap	P/E	Growth	Margin	Compare
ARGX(This stock)	$52.35B	37.3	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN

Data Updated: June 12, 2026 at 10:40 PM EDT

Ready to invest in ARGX?

Commission-free trading available. Affiliate links.

Upcoming Events for ARGX

Dashboard

Enter a ticker to analyze